Pharmacoeconomic review report Tiotropium bromide monohydrate and olodaterol hydrochloride (Inspiolto respimat) for oral inhalation

Pharmacoeconomic review report Tiotropium bromide monohydrate and olodaterol hydrochloride (Inspiolto respimat) for oral inhalation

Inspiolto Respimat (tiotropium bromide monohydrate/olodaterol hydrochloride [TIO/OLO]) is a fixeddose combination of a long-acting muscarinic antagonist (LAMA), tiotropium, and a long-acting beta2 agonist (LABA), olodaterol, indicated for the long-term, once-daily maintenance bronchodilator treatmen...

Descripción completa

Detalles Bibliográficos
Autor principal: Canadian Agency for Drugs and Technologies in Health (author)
Autor Corporativo: Canadian Agency for Drugs and Technologies in Health, author, issuing body (author)
Formato: Libro electrónico
Idioma:Inglés
Publicado: Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health 2015.
Materias:
Economic development projects > Cost effectiveness.
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820267306719

Ejemplares similares

Ejemplares similares